Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Tozaro appoints Jason Slingsby as CEO to lead commercial strategy in cell and gene therapy sector

May 1, 2025 Manufacturing Services, Manufacturing and Production, Research and Development CEO, CGT, Jason Slingsby, Michele Pedrocchi, Pharmacy, Tozaro, manufacturing

Tozaro, a technology provider specialising in cell and gene therapy (CGT) manufacturing, has appointed Jason Slingsby (pictured left) as its …
Appointment

Deadly cancers are being financially left behind, new research claims

May 1, 2025 Research and Development Jude, Oncology, UK, bladder cancer, cancer research, charitable funding

New research has revealed that some of the UK’s most deadly and prevalent cancers receive the least amount of charitable …
News

Neogap chosen for Innovate Nordics 2025 Acceleration Programme

May 1, 2025 Research and Development Innovate Nordics, Neogap Therapeutics, Oncology, biotech, funding programme, immunotherapy

Swedish biotech company Neogap Therapeutics has been chosen to join Innovate Nordics’ 2025 acceleration programme, a prestigious initiative designed to …
News

Cervical cancer experts campaign to increase screening rates and save lives

April 30, 2025 Research and Development NHS, NHS England, Oncology, campaign, cervical cancer, screening

A coalition of experts fighting to end cervical cancer, referred to as the UK Consensus Group of the Advancing Cervical …
News

Novo Nordisk Foundation expands ambitious Challenge Programme internationally 

April 30, 2025 Research and Development Challenge Programme, Denmark, Novo Nordisk, Pharmacy, international

The Novo Nordisk Foundation Challenge Programme, a leading open competition grant programme, invites researchers outside of Denmark to participate and …
News

Ryan Smith appointed as global head of sales at Astoriom

April 29, 2025 Logistics & Distribution, Research and Development Astoriom, Pharmacy, appointment, sample storage solutions

Global R&D sample stability and biorepository storage company, Astoriom, has announced the appointment of Ryan Smith as global head of …
Appointment
europe-1395916_640

EU approval granted for rare kidney disease treatment

April 29, 2025 Market Access, Research and Development, Sales and Marketing CSL Vifor, EU, Nephrology, Travere Therapeutics, kidney disease, nephrology

The EU has granted marketing authorisation (MA) for Filspari – CSL Vifor and Travere Therapeutics’ therapy for primary IgA nephropathy …
News
stethoscope_and_background_doctor

Study finds new test could better predict risk of heart disease

April 28, 2025 Research and Development Cardiology, Chalmers University of Technologyu, Harvard, cholesterol tests, cvd

A study by Harvard University, US, and Chalmers University of Technology, Sweden, has found that measuring a lipoprotein marker combination …
News

McDavid Stilwell appointed as CFO of CPTx

April 28, 2025 Research and Development CPTx, Immunology, Oncology, appointment, cfo, therapeutics

CPTx, a German biotech company focused on single-stranded DNA therapeutics, has announced the appointment of McDavid Stilwell as chief financial …
Appointment
clinical_trials

Successful clinical outcomes for drug treating rare stroke condition

April 25, 2025 Research and Development Bioxodes, Neurology, clinical trial, stroke

Flemish biopharma company, Bioxodes, has announced promising results from the BIRCH phase 2a clinical trial of BIOX-101 to treat intracerebral …
News
trialy

Mosaic Therapeutics in-licenses clinical oncology programmes from Astex Pharma

April 25, 2025 Clinical Trial Services, Industry Associations, Mergers and Acquisitions, Research and Development Astex pharmaceuticals, Mosaic Therapeutics, Oncology, clinical trial

Two clinical-stage oncology programmes from Astex Pharmaceuticals have been announced by Mosaic Therapeutics, allowing it to develop targeted oncology drug …
News

Philippe Masset appointed to Vect-Horus board of directors

April 25, 2025 Research and Development Oncology, Vect-Horus, appointment, board of directors, imaging agents

Vect-Horus has announced the appointment of Philippe Masset to the company’s board of directors. This contributes to a series of …
Appointment
blood_tests_pic

Mursla Bio’s platform for surveillance of liver cancer receives FDA approval

April 24, 2025 Industry Associations, Research and Development BDD, FDA, Mursla Bio, Oncology, hepatocellular carcinoma (HCC), liver disease

The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to EvoLiver, Mursla Bio’s surveillance platform for …
News

Hansa Biopharma appoints Renée Aguiar-Lucander as CEO

April 24, 2025 Research and Development CEO, Corporate, Hansa Biopharma, appointment, immunology

Swedish biopharma company, Hansa Biopharma, has announced the appointment of new chief executive officer (CEO) Renée Aguiar-Lucander, replacing Søren Tulstrup …
Appointment

ViroCell and UCL launch trial to treat childhood leukaemia relapse

April 24, 2025 Research and Development Oncology, UCL, ViroCell, acute lymphoblastic leukaemia, cell therapy, clinical trial, leukaemia

ViroCell Biologics has manufactured a GMP-grade lentiviral vector for a University College London (UCL) clinical trial aimed at tackling relapse …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026